Fast MDx was delighted to read an item in Genome Web covering our system obtaining the CE-IVDR mark for a fully automated, high-throughput open molecular diagnostic test system called NGX 124.
An ‘open’ Molecular Diagnostic system which perfectly describes the Fast MDx platform, would be a “game-changer” in Low- and Middle-Income Countries (LMIC), according to a recent Belgium academic paper published in Expert Review of Molecular Diagnostics .
LabMedica published an article about the Fast MDx Molecular Diagnostic Test System.
A new coalition of industry and health charities, led by former Health Minister, raise the alarm over missed opportunities to tackle Antimicrobial Resistance in the UK.
Fast MDx was delighted to read an excellent article in Genome Web by Justin Petrone, that explains how the platform is being validated by Public Health Wales, which will complete Fast MDx’s UKCA and CE-IVDr regulatory approvals program.
Cervical cancer kills over one third of a million women around the World every year. These deaths can be prevented through a program of vaccination and molecular diagnostic testing.
Canada is currently grappling with a severe shortage of skilled healthcare professionals, particularly in the fields of medical laboratory technology (MLT) and radiology technology (RT). Fast MDx's high-throughput testing can help to ease this situation.
A worryingly high number of cases are being confirmed by NHS England of Pertussis (Whooping Cough) in adolescents and adults, who usually suffer a milder form of the disease but with a cough that may persist for many weeks, hence the nickname of the 100 day cough.
The vaccination programs in the UK for influenza appear to be having good effect this Winter season, with no hospital admissions across the UK for the last 14 days.
Fast MDx receives ISO 13485:2016 certification, setting out the requirements for quality management systems for diagnostics and medical devices.
A review funded by the Bill and Melinda Gates Foundation perfectly explains the greater need for high-throughput Point-of-Care preparedness that only the Fast MDx platform offers.
In a study reported in Nature on 25 September 2023 an immune system biomarker combinations was identified that distinguish Long COVID (LC) cases from those with no persisting symptoms.
COVID-19 metrics have been on the rise in the U.S. for about a month now, indicating that they’re experiencing a summer surge.
Scotland's national clinical director has said he is concerned about winter amid a summer upswing in Covid cases.
A recent review strongly supports the use of repeated testing for circulating tumour DNA (ctDNA), for prognosis and for monitoring for recurrence of solid tumours.
Adding POCT to outpatient triage of ARI can reduce unnecessary antibiotics and anti-biotic-related AEs, resulting in substantial cost savings.
Reported today by Sensitive and Specific that superspreaders are super-shedders and that antigen tests can find them.
The importance of diagnostics was underscored at the recent 2023 World Health Assembly (21-30 May 2023) with the adoption of the WHO’s statement on strengthening diagnostics capacity.
The Fast MDx platform relies on automation technology from Festo for pipetting and dispensing. Included in the system are Festo handling gantries with electric axes, heat sealing from Kbiosystems and Fast MDx’s patented, ultra-fast qPCR thermal cycler, the NGX2.
A UK enterprise has developed a low-cost automated diagnostics test platform that, it says, will slash time and costs, allowing doctors to give patients personalised treatment plans rapidly. The platform makes extensive use of industrial automation technologies.
Read the latest information from Fast MDx on LinkedIn.
